Trials / Unknown
UnknownNCT03715114
A Study to Assess the Safety and Pharmacokinetics of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Subjects
A Double-blind, Randomized, Placebo Controlled Single and Multiple Dose Study to Assess the Safety and Pharmacokinetics of Sodium Oligo-mannurarate (GV-971) Capsule in Healthy Chinese Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Shanghai Greenvalley Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and pharmacokinetics of GV-971 capsules after oral a single or multiple doses of 900 mg, 1200 mg and 1500 mg in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GV-971 | Oral GV-971 |
| DRUG | Placebo | Oral Placebo |
Timeline
- Start date
- 2018-10-15
- Primary completion
- 2018-11-30
- Completion
- 2018-12-31
- First posted
- 2018-10-22
- Last updated
- 2018-10-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03715114. Inclusion in this directory is not an endorsement.